Triazole-resistant candidaemia following posaconazole exposure
- 31 May 2009
- journal article
- other
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 33 (5), 494-495
- https://doi.org/10.1016/j.ijantimicag.2008.12.001
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host DiseaseThe New England Journal of Medicine, 2007
- Aspergillosis—and a misleading sensitivity resultThe Lancet, 2007
- Multiple-Triazole–Resistant AspergillosisThe New England Journal of Medicine, 2007
- Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host DiseaseThe New England Journal of Medicine, 2007
- Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with NeutropeniaThe New England Journal of Medicine, 2007
- Posaconazole: a broad-spectrum triazole antifungalThe Lancet Infectious Diseases, 2005
- Breakthrough Zygomycosis after Voriconazole Treatment in Recipients of Hematopoietic Stem-Cell TransplantsThe New England Journal of Medicine, 2004
- Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with FluconazoleThe New England Journal of Medicine, 1991